We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Thermo Fisher Scientific
TMO
$233B
| $25.6M | 0.05% |
63,046
-12,315
| -16% | -$5.15M |
|
377
XP
XP
$8.97B
| $25.5M | 0.05% |
1,260,707
+1,250,037
| +11,715% | +$21.6M |
|
378
T-Mobile US
TMUS
$191B
| $25.2M | 0.05% |
105,737
+94,801
| +867% | +$23.1M |
|
379
United Rentals
URI
$64.6B
| $25.1M | 0.05% |
33,332
+22,341
| +203% | +$14.9M |
|
380
lululemon athletica
LULU
$13.1B
| $24.9M | 0.05% |
104,980
+99,664
| +1,875% | +$27.5M |
|
381
American Airlines Group
AAL
$9.08B
| $24.8M | 0.05% |
2,213,929
+714,591
| +48% | +$7.65M |
|
382
NVR
NVR
$17B
| $24.8M | 0.05% |
3,362
-371
| -10% | -$2.66M |
|
383
DoubleVerify
DV
$2.07B
| $24.7M | 0.05% |
1,648,952
-14,869
| -0.9% | -$204K |
|
384
ICU Medical
ICUI
$4.38B
| $24.5M | 0.05% |
185,494
-18,034
| -9% | -$2.44M |
|
|
GMS
385
DELISTED
GMS Inc
GMS
| $24.4M | 0.05% |
224,700
-315,238
| -58% | -$24.4M |
|
386
Marathon Petroleum
MPC
$102B
| $24.3M | 0.05% |
145,993
-59,618
| -29% | -$8.94M |
|
|
LIF
387
Life360
LIF
$3.61B
| $24.2M | 0.05% |
371,461
+322,688
| +662% | +$16.6M |
|
388
StoneCo
STNE
$2.2B
| $24.1M | 0.05% |
1,501,896
+318,845
| +27% | +$4.25M |
|
|
OS
389
DELISTED
OneStream Inc
OS
| $24.1M | 0.05% |
850,000
| – | – |
|
390
Albertsons Companies
ACI
$5.94B
| $24M | 0.05% |
1,116,615
+227,257
| +26% | +$4.94M |
|
|
391
Alphabet (Google) Class C
GOOG
$4.13T
| $24M | 0.05% |
135,332
-9,337
| -6% | -$1.54M |
|
392
Citizens Financial Group
CFG
$29.6B
| $23.7M | 0.04% |
530,529
-133,122
| -20% | -$5.24M |
|
393
Brown & Brown
BRO
$23.9B
| $23.6M | 0.04% |
213,101
+199,024
| +1,414% | +$22.4M |
|
394
Lantheus
LNTH
$6.56B
| $23.5M | 0.04% |
286,748
-25,413
| -8% | -$2.23M |
|
|
CHX
395
DELISTED
ChampionX
CHX
| $22.9M | 0.04% |
921,327
-109,912
| -11% | -$2.77M |
|
396
Okta
OKTA
$30.1B
| $22.7M | 0.04% |
227,110
+111,153
| +96% | +$11.9M |
|
397
Fiverr
FVRR
$338M
| $22.6M | 0.04% |
770,000
| – | – |
|
398
Braze
BRZE
$3.84B
| $22.6M | 0.04% |
803,325
+18
| +0% | +$569 |
|
399
Workday
WDAY
$47.8B
| $22.5M | 0.04% |
93,870
-64,320
| -41% | -$15.7M |
|
400
Sarepta Therapeutics
SRPT
$2.28B
| $22.4M | 0.04% |
1,308,199
+1,016,069
| +348% | +$43.3M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.